Table 1 Baseline characteristics in women with and without hysterectomy and oophorectomy.
From: Risk of Hyperlipidemia in Women with Hysterectomy-A Retrospective Cohort Study in Taiwan
Comparison group | Case groups | Hysterectomy only | Hysterectomy + Oophorectomy | Oophorectomy only | p-value cases vs. controls | |
|---|---|---|---|---|---|---|
(n = 28024) | (n = 7006) | (n = 5887) | (n = 563) | (n = 556) | ||
Age, years | ||||||
Mean (SD) | 46.9 (9.01) | 46.9 (9.00) | 46.4 (8.34) | 51.0 (8.35) | 48.5 (13.8) | 0.94 |
<45 | 13255 (47.3) | 3396 (48.5) | 3113 (52.9) | 102 (18.1) | 181 (32.6) | |
45–64 | 13139 (46.9) | 3200 (45.7) | 2476 (42.1) | 418 (74.3) | 306 (55.0) | |
≧65 | 1630 (5.82) | 410 (5.85) | 298 (5.06) | 43 (7.64) | 69 (12.4) | |
Follow-up duration, | ||||||
Mean (SD), years | 5.96 (2.84) | 6.13 (2.63) | 5.95 (3.95) | 7.06 (4.05) | 7.07 (4.36) | <0.0001 |
Hormone therapy* | 3688 (13.2) | 2177 (31.1) | 1558 (26.5) | 360 (63.9) | 259 (46.6) | <0.0001 |
Comorbidity, n (%) | ||||||
Obesity | 169 (0.60) | 69 (0.98) | 61 (1.04) | 4 (0.71) | 4 (0.72) | 0.0005 |
Diabetes | 1204 (4.30) | 344 (4.91) | 268 (4.55) | 38 (6.75) | 38 (6.83) | 0.03 |
CAD | 1592 (5.68) | 480 (6.85) | 365 (6.20) | 53 (9.41) | 62 (11.2) | 0.0002 |
Hypothyroidism | 238 (0.85) | 79 (1.13) | 75 (1.27) | 2 (0.36) | 2 (0.36) | 0.03 |
Hypertension | 3325 (11.9) | 1086 (15.5) | 819 (13.9) | 127 (22.6) | 140 (25.2) | <0.0001 |
